(Q40739552)

23 September 2017

title

A partially humanized monoclonal antibody to human IFN-gamma inhibits cytokine effects both in vitro and in vivo (English)

1 reference

23 September 2017

Fiorentini S

1

1 reference

23 September 2017

De Panfilis G

2

1 reference

23 September 2017

Pasolini G

3

1 reference

23 September 2017

Bonfanti C

4

1 reference

23 September 2017

Caruso A

5

1 reference

23 September 2017

language of work or name

1 reference

1 March 2002

1 reference

Scandinavian Journal of Immunology

23 September 2017

published in

1 reference

23 September 2017

volume

55

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

284-292

1 reference

The IFN gamma receptor: a paradigm for cytokine receptor signaling

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Immune interferon: a pleiotropic lymphokine with multiple effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Primary demyelination in transgenic mice expressing interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

V-region and class specific RT-PCR amplification of human immunoglobulin heavy and light chain genes from B-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

The possibility of distinguishing a subset of antigen-presenting cells from macrophages by means of anti S-100 protein sera. Dermal infiltrate of lichen planus as a model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Interferon gamma receptor extracellular domain expressed as IgG fusion protein in Chinese hamster ovary cells. Purification, biochemical characterization, and stoichiometry of binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

The integrity of the ball-and-socket joint between V and C domains is essential for complete activity of a humanized antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

A binary plasmid system for shuffling combinatorial antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Potential therapeutic use of antibodies directed towards HuIFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

Interferon-γ elicits arteriosclerosis in the absence of leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01039.X

10.1046/J.1365-3083.2002.01039.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference